Fungal infection in a patient with multiple sclerosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 10, 2011, Pages 1173-1180

  Pisa, D ^a   Alonso, R ^a   Carrasco, L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; CORTICOSTEROID; FLUCONAZOLE; FUNGAL DNA; ITRACONAZOLE; KETOCONAZOLE;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BIOASSAY; BLADDER DYSFUNCTION; BLOOD ANALYSIS; CANDIDA; CANDIDA FAMATA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLOT BLOT HYBRIDIZATION; SPASTICITY; SYSTEMIC MYCOSIS;

ADULT; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; BETA-GLUCANS; CANDIDA; CANDIDIASIS; DNA, FUNGAL; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

EID: 80054741468     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1206-1     Document Type: Article

References (40)

1. MD Richardson 2005 Changing patterns and trends in systemic fungal infections J Antimicrob Chemother 56 Suppl 1 i5 i11 16120635 10.1093/jac/dki218 1:CAS:528:DC%2BD2MXpsVaktbk%3D
2. PL White MD Perry RA Barnes 2009 An update on the molecular diagnosis of invasive fungal disease FEMS Microbiol Lett 296 1 1 10 19416355 10.1111/j.1574-6968.2009.01575.x 1:CAS:528:DC%2BD1MXnslGnsb8%3D
3. B De Pauw TJ Walsh JP Donnelly DA Stevens JE Edwards T Calandra PG Pappas J Maertens O Lortholary CA Kauffman DW Denning TF Patterson G Maschmeyer J Bille WE Dismukes R Herbrecht WW Hope CC Kibbler BJ Kullberg KA Marr P Muñoz FC Odds JR Perfect A Restrepo M Ruhnke BH Segal JD Sobel TC Sorrell C Viscoli JR Wingard T Zaoutis JE Bennett 2008 Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 12 1813 1821 18462102 10.1086/588660
4. C Speth G Rambach R Würzner C Lass-Flörl 2008 Complement and fungal pathogens: an update Mycoses 51 6 477 496 18705662 10.1111/j.1439-0507. 2008.01597.x 1:CAS:528:DC%2BD1cXhtlyjtLfK
5. MG Netea L Maródi 2010 Innate immune mechanisms for recognition and uptake of Candida species Trends Immunol 31 9 346 353 20705510 10.1016/j.it.2010.06.007 1:CAS:528:DC%2BC3cXhtFals7vM
6. L Polonelli A Casadevall Y Han F Bernardis TN Kirkland RC Matthews D Adriani M Boccanera JP Burnie A Cassone S Conti JE Cutler R Frazzi C Gregory S Hodgetts C Illidge W Magliani G Rigg G Santoni 2000 The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections Med Mycol 38 Suppl 1 281 292 11204156
7. M Richardson R Rautemaa 2009 How the host fights against Candida infections Front Biosci (Schol Ed) 1 246 257
8. L Romani 1999 Immunity to Candida albicans: Th1, Th2 cells and beyond Curr Opin Microbiol 2 4 363 367 10458979 10.1016/S1369-5274(99)80064-2 1:CAS:528:DyaK1MXlslyls70%3D
9. PF Zipfel R Würzner C Skerka 2007 Complement evasion of pathogens: common strategies are shared by diverse organisms Mol Immunol 44 16 3850 3857 17768102 10.1016/j.molimm.2007.06.149 1:CAS:528:DC%2BD2sXpsl2htrw%3D
10. SC Chen CL Halliday W Meyer 2002 A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays Med Mycol 40 4 333 357 12230214 1:CAS:528: DC%2BD38Xns1amsLo%3D
11. S Bretagne JM Costa 2005 Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis FEMS Immunol Med Microbiol 45 3 361 368 16054349 10.1016/j.femsim.2005.05.012 1:CAS:528:DC%2BD2MXpvFemsb4%3D
12. MT Montagna G Caggiano E Borghi G Morace 2009 The role of the laboratory in the diagnosis of invasive candidiasis Drugs 69 Suppl 1 59 63 19877736 10.2165/11315630-000000000-00000
13. JL López-Ribot M Casanova A Murgui JP Martínez 2004 Antibody response to Candida albicans cell wall antigens FEMS Immunol Med Microbiol 41 3 187 196 15196567 10.1016/j.femsim.2004.03.012
14. J Pontón 2009 Usefulness of biological markers in the diagnosis of invasive candidiasis Rev Iberoam Micol 26 1 8 14 19463272 10.1016/S1130- 1406(09)70003-8
15. M Ramos D Pisa S Molina A Rábano Á Juarranz L Carrasco 2008 Fungal infection in patients with multiple sclerosis Open Mycol J 2 22 28 10.2174/1874437000802010022 1:CAS:528:DC%2BD1cXlslensrw%3D
16. L Carrasco M Ramos R Galisteo D Pisa M Fresno ME González 2005 Isolation of Candida famata from a patient with acute zonal occult outer retinopathy J Clin Microbiol 43 2 635 640 15695657 10.1128/JCM.43.2.635-640.2005
17. D Pisa M Ramos S Molina P García L Carrasco 2007 Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata J Med Microbiol 56 Pt 5 571 578 17446276 10.1099/jmm.0.47042-0 1:CAS:528:DC%2BD2sXmtVCmt7o%3D
18. D Pisa M Ramos P García R Escoto R Barraquer S Molina L Carrasco 2008 Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy J Clin Microbiol 46 1 130 135 18003800 10.1128/JCM.02605-06 1:CAS:528:DC%2BD1cXhs1aqtLY%3D
19. DM Jacobson 1996 Acute zonal occult outer retinopathy and central nervous system inflammation J Neuroophthalmol 16 3 172 177 8865008 1:STN:280: DyaK2s%2FhvVeqsA%3D%3D
20. HL Weiner 2008 A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis J Neurol 255 Suppl 1 3 11 18317671 10.1007/s00415-008-1002-8 1:CAS:528:DC%2BD1cXovV2rtbY%3D
21. CK Glass K Saijo B Winner MC Marchetto FH Gage 2010 Mechanisms underlying inflammation in neurodegeneration Cell 140 6 918 934 20303880 10.1016/j.cell.2010.02.016 1:CAS:528:DC%2BC3cXlsVSgu7Y%3D
22. A Kutzelnigg CF Lucchinetti C Stadelmann W Brück H Rauschka M Bergmann M Schmidbauer JE Parisi H Lassmann 2005 Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 Pt 11 2705 2712 16230320 10.1093/brain/awh641
23. MH Barnett I Sutton 2006 The pathology of multiple sclerosis: a paradigm shift Curr Opin Neurol 19 3 242 247 16702829 10.1097/01.wco.0000227032.47458.cb
24. R Gandhi A Laroni HL Weiner 2010 Role of the innate immune system in the pathogenesis of multiple sclerosis J Neuroimmunol 221 1-2 7 14 19931190 10.1016/j.jneuroim.2009.10.015 1:CAS:528:DC%2BC3cXks1Sjsr4%3D
25. K Venken N Hellings R Liblau P Stinissen 2010 Disturbed regulatory T cell homeostasis in multiple sclerosis Trends Mol Med 16 2 58 68 20159585 10.1016/j.molmed.2009.12.003 1:CAS:528:DC%2BC3cXitVKgsbk%3D
26. J Sánchez-Portocarrero E Pérez-Cecilia O Corral J Romero-Vivas JJ Picazo 2000 The central nervous system and infection by Candida species Diagn Microbiol Infect Dis 37 3 169 179 10904190 10.1016/S0732-8893(00) 00140-1
27. J Benito-León D Pisa R Alonso P Calleja M Díaz- Sánchez L Carrasco 2010 Association between multiple sclerosis and Candida species: evidence from a case-control study Eur J Clin Microbiol Infect Dis 29 9 1139 1145 20556470 10.1007/s10096-010-0979-y
28. C Pazos J Pontón A Del Palacio 2005 Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan J Clin Microbiol 43 1 299 305 15634986 10.1128/JCM.43.1.299-305.2005 1:CAS:528:DC%2BD2MXhtF2nu74%3D
29. EM Frohman MK Racke CS Raine 2006 Multiple sclerosis-the plaque and its pathogenesis N Engl J Med 354 9 942 955 16510748 10.1056/NEJMra052130 1:CAS:528:DC%2BD28XitVertLc%3D
30. H Santelmann JM Howard 2005 Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome Eur J Gastroenterol Hepatol 17 1 21 26 15647635 10.1097/00042737-200501000-00005
31. DH Gilden 2005 Infectious causes of multiple sclerosis Lancet Neurol 4 3 195 202 15721830 1:CAS:528:DC%2BD2MXis1Slt7g%3D
32. G Giovannoni GR Cutter J Lunemann R Martin C Münz S Sriram I Steiner MR Hammerschlag CA Gaydos 2006 Infectious causes of multiple sclerosis Lancet Neurol 5 10 887 894 16987736 10.1016/S1474-4422(06)70577-4
33. ZU Khan VC Misra HS Randhawa VN Damodaran 1980 Pathogenicity of some ordinarily harmless yeasts for cortisone-treated mice Sabouraudia 18 4 319 327 7455862 10.1080/00362178085380521 1:STN:280:DyaL3M7gtlGgtA%3D%3D
34. GW Procop GD Roberts 2004 Emerging fungal diseases: the importance of the host Clin Lab Med 24 3 691 719 15325061 10.1016/j.cll.2004.05.004 vi-vii
35. MR Brown CA Thompson FM Mohamed 2005 Systemic candidiasis in an apparently immunocompetent dog J Vet Diagn Invest 17 3 272 276 15945387 10.1177/104063870501700312
36. ZM Lenard NV Lester AJ O'Hara BJ Hopper GD Lester 2007 Disseminated cryptococcosis including osteomyelitis in a horse Aust Vet J 85 1-2 51 55 17300456 10.1111/j.1751-0813.2006.00060.x 1:STN:280:DC%2BD2s7gtFKlsQ%3D%3D quiz 85
37. CB Purzycki DH Shain 2010 Fungal toxins and multiple sclerosis: a compelling connection Brain Res Bull 82 1-2 4 6 20214953 10.1016/j.brainresbull. 2010.02.012 1:CAS:528:DC%2BC3cXlsFaju7o%3D
38. A Ménard R Amouri T Dobránsky C Charriaut-Marlangue R Pierig C Cifuentes-Diaz S Ghandour J Belliveau H Gascan F Hentati O Lyon-Caen H Perron F Rieger 1998 A gliotoxic factor and multiple sclerosis J Neurol Sci 154 2 209 221 9562313 10.1016/S0022-510X(97)00231-1
39. R Pierig J Belliveau R Amouri A Ménard F Rieger 2002 Association of a gliotoxic activity with active multiple sclerosis in US patients Cell Mol Biol (Noisy-le-Grand) 48 2 199 203 1:CAS:528:DC%2BD38XjvFSgsb0%3D
40. M Pacheco D Pisa P García-Gómez L Carrasco A Juarranz 2007 Attachment and entry of Candida famata in monocytes and epithelial cells Microsc Res Tech 70 11 975 986 17661391 10.1002/jemt.20503